MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2017 International Congress

    Oral health-related quality of life and dental care among Parkinson’s disease patients and Care givers of South India.

    E. Aluckal (Ernakulam, India)

    Objective: The objective of the present study was to evaluate the oral health-related quality of life among patients and their caregivers with Parkinson's disease. Background: Parkinson's disease can severely…
  • 2017 International Congress

    Sex Differences in Homebound Advanced Parkinson’s Disease Patients

    L. Nwabuobi, W. Barbosa, M. Sweeney, S. Oyler, A. Lemen, T. Meisel, A. Di Rocco, J. Chodosh, J. Fleisher (New York, NY, USA)

    Objective: To describe sex differences in homebound patients with advanced Parkinson’s disease and related disorders in an interdisciplinary home visit program (HVP) Background: It has…
  • 2017 International Congress

    An association between impulse control disorders and dopamine agonists in Japanese patients with Parkinson’s disease.

    Y. Yamanishi, R. Ando, C. Yamasaki, S. Tada, N. Miyaue, H. Iwaki, H. Yabe, N. Nishikawa, M. Nagai, M. Nomoto (Ehime, Japan)

    Objective: To evaluate an association between impulse control disorders (ICDs) and dopamine agonists (DA) therapy in Japanese patients with Parkinson’s disease (PD). Background: ICDs such…
  • 2017 International Congress

    A double-blind, randomized, placebo controlled study of botulinum toxin type A for limb pain in advanced Parkinson’s disease

    V. Bruno, M. Freitas, D. Mancini, J. Liu, J. Miyasaki, S. Fox (CABA, Argentina)

    Objective: To evaluate safety, tolerability and efficacy of botulinum toxin type A for limb pain in advanced Parkinson´s disease (PD). Background: Pain is a frequent…
  • 2017 International Congress

    Evaluation of a Radiographic Marker as a Diagnostic Tool For Progressive Supranuclear Palsy

    P. Dowell, B. Patel, L. Ledbetter, K. Lyons, R. Pahwa (Kansas City, KS, USA)

    Objective: To evaluate the sensitivity and specificity of a radiographic marker, midbrain to pons ratio, in brain MRI of Progressive Supranuclear Palsy (PSP) patients as…
  • 2017 International Congress

    Rolipram, a PDE-IV inhibitor protects against experimental Parkinsonism in mice

    N. KUMAR, R. Khanna (Jaipur, India)

    Objective: Rolipram, a specific inhibitor of the phosphodiesterase IV (PDE IV), has recently been shown to exert neuroprotective effects in an Alzheimer transgenic mouse model…
  • 2017 International Congress

    Parkinsonism Revealing Cerebral Hematoma with Moya Moya Disease

    z. brahem, i. bedoui, a. riahi, m. mansour, j. zaouali, r. mrissa (tunis, Tunisia)

    Objective: The aim of this study is to describe a rare cause of parkinsonism. Background: Moyamoya disease (MMD), a rare chronic, progressive cerebrovascular disease leads…
  • 2017 International Congress

    Mindfulness for People with Parkinson’s: Emotional Well Being, Social Support and Group Effect

    B. Pickut, S. Woolner, R. Nyenhuis, D. Nyenhuis (Grand Rapids, MI, USA)

    Objective: ObjectiveTo investigate the effects of a 8-week MBSR group training on the quality of life of People with Parkinson's (PwP). Background: Little is known…
  • 2017 International Congress

    Deep Brain Stimulation for Parkinson’s disease: Short-term outcomes, referral patterns and health disparities.

    D. Di Luca, V. Aldahondo, W. Jermakowicks, L. Segala, H. Moore, C. Singer, B. Levin, J. Jagid, C. Luca (Miami, FL, USA)

    Objective: To describe the practice patterns at University of Miami (UM), short term outcomes and health disparities among ethnic groups. Background: Deep brain stimulation (DBS)…
  • 2017 International Congress

    Factors determining the motor outcome of STN DBS in PD patients: Evidence for Dual Actions

    C. Lee, E.J. Choi, S.-C. Park, J.K. Lee (Seoul, Republic of Korea)

    Objective: We investigated factors determining the motor outcome of STN DBS in patients with Parkinson disease (PD). Background: The STN DBS has revolutionized the management…
  • « Previous Page
  • 1
  • …
  • 296
  • 297
  • 298
  • 299
  • 300
  • …
  • 388
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
  • An atypical and interesting feature of Parkinson´s disease
  • Patients with Essential Tremor Live Longer than their Relatives
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley